AB.PA
Price:
$0.78
Market Cap:
$45.11M
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-04-26
Stock Exchange
EURONEXT
Ticker
AB.PA
According to AB Science S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -11.14. This represents a change of -58.55% compared to the average of -26.88 of the last 4 quarters.
The mean historical PE Ratio of AB Science S.A. over the last ten years is -22.38. The current -11.14 PE Ratio has changed 4.88% with respect to the historical average. Over the past ten years (40 quarters), AB.PA's PE Ratio was at its highest in in the June 2024 quarter at -3.09. The PE Ratio was at its lowest in in the March 2021 quarter at -74.70.
Average
-22.38
Median
-17.90
Minimum
-57.79
Maximum
-5.03
Discovering the peaks and valleys of AB Science S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 492.95%
Maximum Annual PE Ratio = -5.03
Minimum Annual Increase = -58.36%
Minimum Annual PE Ratio = -57.79
Year | PE Ratio | Change |
---|---|---|
2023 | -18.19 | -25.90% |
2022 | -24.55 | -37.74% |
2021 | -39.43 | -31.78% |
2020 | -57.79 | 492.95% |
2019 | -9.75 | 93.87% |
2018 | -5.03 | -58.36% |
2017 | -12.07 | -31.43% |
2016 | -17.61 | 11.20% |
2015 | -15.83 | -32.71% |
2014 | -23.53 | -23.89% |
The current PE Ratio of AB Science S.A. (AB.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.39
5-year avg
-29.94
10-year avg
-22.38
AB Science S.A.’s PE Ratio is less than Innate Pharma S.A. (-4.02), less than Genfit S.A. (128.35), less than Nanobiotix S.A. (-4.49), less than ERYTECH Pharma S.A. (-0.48), less than Adocia SA (-2.87),
Company | PE Ratio | Market cap |
---|---|---|
-4.02 | $137.13M | |
128.35 | $182.49M | |
-4.49 | $150.38M | |
-0.48 | $48.66M | |
-2.87 | $111.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AB Science S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AB Science S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AB Science S.A.'s PE Ratio?
How is the PE Ratio calculated for AB Science S.A. (AB.PA)?
What is the highest PE Ratio for AB Science S.A. (AB.PA)?
What is the 3-year average PE Ratio for AB Science S.A. (AB.PA)?
What is the 5-year average PE Ratio for AB Science S.A. (AB.PA)?
How does the current PE Ratio for AB Science S.A. (AB.PA) compare to its historical average?